Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEXT-HF
NCT06995144Phase 4Withdrawn
- Start
- May 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of torasemide in heart failure (HF). Planned start May 2025; status: withdrawn.
02
Drugs
torasemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT06995144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06995144.